Already a Bloomberg.com user?
Sign in with the same account.
HENDERSON, Nev. (AP) — Spectrum Pharmaceuticals Inc. said Tuesday that it hired former Amgen executive Ken Keller as its chief operating officer.
Spectrum said Keller, 49, will be in charge of its pharmaceutical, medical and clinical, and commercial operations. The company said Keller worked at Amgen Inc. for 21 years, most recently as the general manager of its bone health division.
Before that he led the company's anti-inflammatory drug business, and Keller has also managed Amgen's U.K. and Ireland business. Amgen is the world's largest biotech drug company and is based in Thousand Oaks, Calif.
The move comes a few days after Spectrum, which is based in Henderson, Nev., completed its purchase of lymphoma drug maker Allos Therapeutics Inc.
Spectrum Pharmaceuticals shares rose 8 cents to $11.95 in morning trading. Its shares have fallen 32 percent since peaking for the past year at $17.48 on July 10.